Science

Apr 24, 2025, 10:12

Myeloma Paper of the Day, April 24th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: IVIg supplementation in recipients of BCMA-directed TCEs for myeloma may be associated with improved outcomes, including favorable infection-free and overall survival; extramedullary and high-risk disease confer poor outcomes.”

“Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma”

Authors: Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi Shah, Carolina Schinke et al.

More posts featuring Robert Orlowski.

Aniko Szabo Anita D'Souza Anna Clennon cancer Carolina Schinke Heloise Cheruvalath Intravenous Immunoglobulin IVIG Mansi Shah Meera Mohan multiple myeloma Myeloma Paper of the Day Nishi Shah OncoDaily Oncology Rajshekhar Chakraborty Robert Orlowski Vineel Bhatlapenumarthi

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...